Pfizer-BioNTech produces Corona Vaccine for adolescents, FDA approved for emergency use

HealthPfizer-BioNTech produces Corona Vaccine for adolescents, FDA approved for emergency use

Date:

Pfizer-BioNTech produces Corona Vaccine for adolescents, FDA approved for emergency use

Amid the ongoing war against the Corona epidemic, a great hope has been raised towards protecting children from infection. The US Food and Drug Administration (FDA), in a major decision, has approved the emergency use of Pfizer-BioNTech COVID Vaccine for adolescents. This vaccine will be given to those aged 12–15 years. Vaccination of children between 12 and 15 years of age can begin in the US this week. FDA acting commissioner Janet Woodcock called the move an important step in the fight against the Corona epidemic.

Read also: Vaccine formula should be shared with other companies: Kejriwal

Let me tell you that in addition to Pfizer for the vaccination of children, Moderna is also doing trials and soon her results can also be revealed. The special thing is that the FDA has expressed confidence in the results of the two companies so far. Another US company NovaVax has a COVID-19 vaccine in its final stages and has also started a study on 12- to 17-year-olds.

Share post:

Subscribe

Popular

More like this
Related

Top 7 Reasons to Cancel an E-Way Bill

E-Way Bills (EWB) were implemented in India in 2018,...

Gopal Vittal appointed as Acting Chair of the GSMA Board

Gurugram (India), February, 2025: Gopal Vittal, Vice Chairman &...